Market: NASD |
Currency: USD
Address: 9920 Pacific Heights Blvd.
MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. It develops ME-344, an intravenous small molecule inhibitor mitochondrial oxidative phosphorylation to treat human epidermal growth factor receptor 2 negative breast cancer, colorectal cancer, and solid tumors. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California.
📈 MEI Pharma, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
<0%
-
Upcoming Earnings Date:
2025-09-26
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2023 |
- |
$1.750000 |
- |
2023-11-16 |
- |
Dividend payout |
| $0.050000 |
- |
2023-04-17 |
- |
Stock split |
|
Total Amount for 2023: $1.800000 |
📅 Earnings & EPS History for MEI Pharma, Inc.
| Date | Reported EPS |
|---|
| 2025-09-25 (estimated upcoming) | - |
| 2024-09-19 | -1.13 |
| 2024-05-09 | -1.37 |
| 2024-02-13 | -1.66 |
| 2023-11-09 | 8.46 |
| 2023-09-26 | -1.75 |
| 2023-05-11 | -2.32 |
| 2023-02-09 | 1.46 |
| 2022-11-14 | -2.66 |
| 2022-09-08 | -2.34 |
| 2022-05-23 | -3.23 |
| 2022-02-10 | -1.78 |
| 2021-11-10 | -2.2 |
| 2021-09-02 | -2.24 |
| 2021-05-06 | -3.92 |
| 2021-02-04 | -2 |
| 2020-11-10 | -0.4 |
| 2020-09-09 | -6.91 |
| 2020-05-07 | -2.28 |
| 2020-02-06 | -3 |
| 2019-11-07 | -3.33 |
| 2019-08-28 | -2.96 |
| 2019-05-09 | -3.42 |
| 2019-02-07 | -3.21 |
| 2018-11-08 | -2.8 |
📰 Related News & Research
No related articles found for "mei pharma".
